InterCure to Be Featured with Mike Tyson in an Exclusive Interview on Fox Business
15. Mai 2023 08:30 ET
|
InterCure Ltd.
NEW YORK and TORONTO and HERZLIYA, Israel, May 15, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) ("InterCure'' or the "Company"), the largest and fastest growing medical...
InterCure Informs That A Lawsuit Was Filed Against the Company by Minority Shareholders of Its Subsidiary
25. April 2023 19:19 ET
|
InterCure Ltd.
NEW YORK and TORONTO and HERZLIYA, Israel, April 25, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading...
InterCure Informs That An Application To Approve a Class Action Against 26 Cannabis Companies in Israel, Including InterCure, Was Filed to The Court In Israel
24. April 2023 17:59 ET
|
InterCure Ltd.
NEW YORK, TORONTO, and HERZLIYA, Israel, April 24, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading...
InterCure Ltd. Partners with TYSON 2.0 in Israel, Australia, United Kingdom, Germany and Other EU Countries
20. April 2023 08:30 ET
|
InterCure Ltd.
NEW YORK and TORONTO and HERZLIYA, Israel, April 20, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading...
InterCure Reschedules 2022 Full Year Results Conference Call
03. April 2023 15:27 ET
|
InterCure Ltd.
NEW YORK, TORONTO, and HERZLIYA, Israel, April 03, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) announced today that...
InterCure Announces Record Fourth Quarter and Fiscal Year End 2022 Results
31. März 2023 20:00 ET
|
InterCure Ltd.
Record fiscal year 2022 revenue of $150 million Record fiscal year 2022 Adjusted EBITDA* of $32 million Record fiscal year 2022 net income of $17 million Generated $20 Million cash flow from...
InterCure Files Lawsuit Against Cann Pharmaceuticals to Recover Funds Following Failed Merger
14. Februar 2023 08:30 ET
|
InterCure Ltd.
NEW YORK, TORONTO, and HERZLIYA, Israel, Feb. 14, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)(“InterCure” or the “Company”) the biggest and most...
InterCure Announces the Termination of its Acquisition Agreement with Cann Pharmaceutical (dba Better)
01. Februar 2023 08:30 ET
|
InterCure Ltd.
NEW YORK and TORONTO and HERZLIYA, Israel, Feb. 01, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company") announces that,...
InterCure Announces Exclusive International Partnership Agreement with Award Winning Cannabis Brand "Binske"
19. Dezember 2022 08:30 ET
|
InterCure Ltd.
NEW YORK and TORONTO and HERZLIYA, Israel, Dec. 19, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the largest and...
InterCure to Participate in Cowen 5th Annual Cannabis Conference
08. Dezember 2022 09:30 ET
|
InterCure Ltd.
NEW YORK and TORONTO and HERZLIYA, Israel, Dec. 08, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that...